| |
|
|
|
|
|
|
|||
|
Blood, 15 December 2008, Vol. 112, No. 13, pp. 4862-4873. Prepublished online as a Blood First Edition Paper on October 7, 2008; DOI 10.1182/blood-2008-01-136564.
Submitted January 30, 2008
MRC Hematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, Oxon, United Kingdom * Corresponding author; email: tenver{at}gwmail.jr2.ox.ac.uk.
The zinc finger transcription factor GATA-2 has been implicated in the regulation of hematopoietic stem cells. Herein we explored the role of GATA-2 as a candidate regulator of the hematopoietic progenitor cell compartment. We showed that bone marrow from GATA-2 heterozygote (GATA-2+/-) mice displayed attenuated granulocyte-macrophage progenitor function in colony-forming cell (CFC) and serial replating CFC assays. This defect was mapped to the Lin-CD117+Sca-1-CD34+CD16/32high granulocyte-macrophage progenitor (GMP) compartment of GATA-2+/- marrow, which was reduced and functionally impaired in CFC assays and competitive transplantation. Similar functional impairments were obtained using a RNA interference approach to stably knockdown GATA-2 in wild-type GMP. While apoptosis and cell cycle distribution remained unperturbed in GATA-2+/- GMP, quiescent cells from GATA-2+/- GMP exhibited altered functionality. Gene expression analysis revealed attenuated expression of HES-1 mRNA in GATA-2 deficient GMPs. Binding of GATA-2 to the HES-1 locus was detected in the myeloid progenitor cell line 32Dcl3 and enforced expression of HES-1 expression in GATA-2+/- GMP rectified the functional defect, suggesting that GATA-2 regulates myeloid progenitor function through HES-1. These data collectively point to GATA-2 as novel, pivotal determinant of GMP cell fate.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||